STATE STREET CORP - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 95 filers reported holding ONCOCYTE CORP in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$64,824
-35.1%
281,8450.0%0.00%
Q1 2023$99,886
-44.8%
281,845
-50.0%
0.00%
Q4 2022$180,888
-12.2%
563,690
+100.0%
0.00%
Q3 2022$206,000
-29.9%
281,845
-13.8%
0.00%
Q2 2022$294,000
-85.5%
327,145
-75.9%
0.00%
Q1 2022$2,023,000
-32.7%
1,357,513
-2.0%
0.00%
Q4 2021$3,006,000
-39.8%
1,385,461
-1.3%
0.00%
Q3 2021$4,997,000
-31.1%
1,403,564
+11.1%
0.00%
Q2 2021$7,251,000
+25.9%
1,263,199
+13.9%
0.00%
Q1 2021$5,758,000
+158.3%
1,109,356
+19.0%
0.00%
Q4 2020$2,229,000
+134.1%
932,480
+36.2%
0.00%
Q3 2020$952,000
-20.2%
684,637
+9.6%
0.00%
Q2 2020$1,193,000
+13.5%
624,652
+45.7%
0.00%
Q1 2020$1,051,000
+7.4%
428,858
-1.5%
0.00%
Q4 2019$979,000
+10.7%
435,208
+3.4%
0.00%
Q3 2019$884,000
+0.8%
420,833
+19.4%
0.00%
Q2 2019$877,000
+2148.7%
352,320
+1834.7%
0.00%
Q1 2018$39,000
-46.6%
18,211
+14.5%
0.00%
Q4 2017$73,000
-55.2%
15,899
-56.0%
0.00%
Q1 2016$163,00036,1260.00%
Other shareholders
ONCOCYTE CORP shareholders Q2 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,056,680$15,895,0002.92%
IHT Wealth Management, LLC 200$386,0000.19%
Family Management Corp 22,570$117,0000.08%
Artal Group S.A. 150,000$780,0000.01%
Destination Wealth Management 29,656$154,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 145,000$754,0000.01%
WELLS FARGO & COMPANY/MN 99$00.00%
NORTHERN TRUST CORP 40,732$211,0000.00%
Vantage Investment Advisors, LLC 25$00.00%
FIFTH THIRD BANCORP 210$1,0000.00%
View complete list of ONCOCYTE CORP shareholders